Odimma develops personalized immunotherapy using AI and synthetic DNA technology.
Odimma develops personalized immunotherapy using AI and synthetic DNA technology.
Wheeleo is developing an innovative walking aid solution for greater independence and reduced risk of falls.
Tele-rehabilitation solutions for patients with long-term conditions.
Genexpath produces and markets cancer characterization kits combined with results analysis software.
Healshape is developing a personalized, natural, regenerative and resorbable bioprosthesis for women who have undergone a mastectomy following breast cancer.
GAOMA Therapeutics est une société de biotechnologie développant des lipides en tant que nouveaux médicaments, avec un accent particulier sur l’épilepsie et les troubles cognitifs.
Home automation solution for the mobility-impaired and visually impaired.
Stimuli has developed Tensi+, a medical device for treating bladder hyperactivity using TENS (Transcutaneous Electrical Nerve Stimulation) technology.
Development of the first intranasal vaccine against bronchiolitis and viral pneumonia caused by human metapneumovirus and RSV.
Open Stent Solution est à l’origine de la première valve mitrale stentée en forme de ruban pour un remplacement transcathéter.
Experience-sharing platform for users, patients and professionals. Automatic creation of personalized care paths for chronically ill patients.
Induction ultra-rapide de l’hypothermie thérapeutique dans le syndrome post arrêt cardiaque.
Apmonia Therapeutics is developing a pipeline of next-generation peptide therapies targeting the tumor microenvironment to improve the lives of cancer patients.
"We believe that when it comes to seed financing in the healthcare sector, an innovative start-up can effectively benefit from the support of such a specialized investor, as they understand the specificity of our business model much better than generalist business angels or family office and they are more flexible than life science VCs."
"Angels Santé, in addition to other investors, has given Abcely credibility for its project in the eyes of other, more generalist co-investors, less able to appreciate the real challenges that can be encountered by a biotech company in the healthcare field, more specifically in oncology."
"Angel Santé gives you access to a network of professional investors in the healthcare sector who are keen to get involved in your company's development. Beyond financing, you gain access to invaluable skills in a sector of expertise."
The club offers quarterly physical meetings, co-hosted by entrepreneurs themselves. You benefit from their feedback on a specific theme.
Sessions are co-hosted by other speakers (associate corporate members, ecosystem players, etc.) sharing their expertise.
